acetaminophen has been researched along with Bladder Cancer in 22 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case of a patient receiving long-term anticoagulation with warfarin who had supratherapeutic International Normalized Ratios (INRs) after receiving concomitant acetaminophen and moxifloxacin as prophylaxis with bacille Calmette-Guérin (BCG) therapy for bladder cancer is reported." | 7.77 | Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. ( Berube, C; Lee, R; Wen, A, 2011) |
| "We conducted a nested, matched case-control study in the General Practice Research Database (GPRD) to assess whether acetaminophen use is associated with renal or bladder cancer." | 7.71 | Acetaminophen and the risk of renal and bladder cancer in the general practice research database. ( Jick, H; Kaye, JA; Myers, MW, 2001) |
| "Acetaminophen is a metabolite of phenacetin, a drug that has been implicated as a causal agent in the development of renal and bladder cancer." | 7.69 | Acetaminophen and renal and bladder cancer. ( Derby, LE; Jick, H, 1996) |
| "We investigated the use of analgesics containing phenacetin or acetaminophen in 173 young women with urinary bladder cancer and 173 matched controls." | 7.67 | Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. ( Matanoski, GM; Piper, JM; Tonascia, J, 1985) |
| "Phenacetin was withdrawn from the Danish market on 1." | 6.38 | [Phenacetin, paracetamol and bladder cancer]. ( Jensen, OM; Nørgaard, N, 1990) |
| "The results of our meta-analysis suggest that there is no association between use of acetaminophen, aspirin or non-aspirin NSAIDs and bladder cancer risk." | 4.89 | Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. ( Jiang, D; Li, X; Zhang, H, 2013) |
| "The case of a patient receiving long-term anticoagulation with warfarin who had supratherapeutic International Normalized Ratios (INRs) after receiving concomitant acetaminophen and moxifloxacin as prophylaxis with bacille Calmette-Guérin (BCG) therapy for bladder cancer is reported." | 3.77 | Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. ( Berube, C; Lee, R; Wen, A, 2011) |
| " However, acetaminophen, a major metabolite of phenacetin, may be positively associated with bladder cancer risk." | 3.74 | Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study. ( De Vivo, I; Genkinger, JM; Giovannucci, E; Michaud, DS; Stampfer, MJ, 2007) |
| "We conducted a nested, matched case-control study in the General Practice Research Database (GPRD) to assess whether acetaminophen use is associated with renal or bladder cancer." | 3.71 | Acetaminophen and the risk of renal and bladder cancer in the general practice research database. ( Jick, H; Kaye, JA; Myers, MW, 2001) |
| "Acetaminophen is a metabolite of phenacetin, a drug that has been implicated as a causal agent in the development of renal and bladder cancer." | 3.69 | Acetaminophen and renal and bladder cancer. ( Derby, LE; Jick, H, 1996) |
| "We investigated the use of analgesics containing phenacetin or acetaminophen in 173 young women with urinary bladder cancer and 173 matched controls." | 3.67 | Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. ( Matanoski, GM; Piper, JM; Tonascia, J, 1985) |
| " Studies of the relationship between genotoxicity and toxic effects in the rat (induction of micronuclei in rat bone marrow including dose-response relationship, biotransformation of paracetamol at different dosages, concomitant toxicity and biochemical markers) have recently been completed." | 2.39 | Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. ( Bergman, K; Müller, L; Teigen, SW, 1996) |
| "Phenacetin was withdrawn from the Danish market on 1." | 2.38 | [Phenacetin, paracetamol and bladder cancer]. ( Jensen, OM; Nørgaard, N, 1990) |
| "Acetaminophen pretreatment decreases the sulfate availability, but results in many side effects that complicate the analysis of the results." | 2.36 | Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: the role of N,O-sulfonation in chemical carcinogenesis of aromatic amines. ( Meerman, JH; Mulder, GJ, 1983) |
| "Bladder cancer is one of the most common urogenital tumors." | 1.51 | Can intravesical application of paracetamol benefit the chemotherapy treatment of bladder cancer? ( Buğday, MS; Öksüz, E, 2019) |
| "A case of painful priapism is reported in a patient who had previously suffered a radical cystectomy for bladder carcinoma pT3-GIII, followed by local recurrence in the pelvis." | 1.29 | Priapism of the clitoris. ( Arteaga, PR; Galbis, F; Monllor, J; Taño, F, 1996) |
| "0% dosage level, 20% of rats of both sexes developed neoplastic nodules of the liver, a statistically significant incidence." | 1.27 | Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure. ( Flaks, A; Flaks, B; Shaw, AP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Öksüz, E | 1 |
| Buğday, MS | 1 |
| Zhang, H | 1 |
| Jiang, D | 1 |
| Li, X | 1 |
| Lee, R | 1 |
| Wen, A | 1 |
| Berube, C | 1 |
| Genkinger, JM | 1 |
| De Vivo, I | 1 |
| Stampfer, MJ | 1 |
| Giovannucci, E | 1 |
| Michaud, DS | 1 |
| Tsuda, H | 1 |
| Fukushima, S | 2 |
| Imaida, K | 1 |
| Sakata, T | 1 |
| Ito, N | 1 |
| Mulder, GJ | 1 |
| Meerman, JH | 1 |
| Bach, PH | 2 |
| Bridges, JW | 2 |
| Andersson, B | 1 |
| Nordenskjöld, M | 1 |
| Rahimtula, A | 1 |
| Moldéus, P | 1 |
| Bergman, K | 1 |
| Müller, L | 1 |
| Teigen, SW | 1 |
| Derby, LE | 1 |
| Jick, H | 2 |
| Monllor, J | 1 |
| Taño, F | 1 |
| Arteaga, PR | 1 |
| Galbis, F | 1 |
| Kaye, JA | 1 |
| Myers, MW | 1 |
| Nørgaard, N | 1 |
| Jensen, OM | 1 |
| Dolara, P | 1 |
| Lodovici, M | 1 |
| Salvadori, M | 1 |
| Saltutti, C | 1 |
| Delle Rose, A | 1 |
| Selli, C | 1 |
| Kriebel, D | 1 |
| McCredie, M | 1 |
| Stewart, JH | 1 |
| Kurata, Y | 1 |
| Asamoto, M | 1 |
| Hagiwara, A | 1 |
| Masui, T | 1 |
| Piper, JM | 1 |
| Tonascia, J | 1 |
| Matanoski, GM | 1 |
| Flaks, B | 1 |
| Flaks, A | 1 |
| Shaw, AP | 1 |
| Bengtsson, V | 1 |
| Weisburger, JH | 1 |
| Weisburger, EK | 1 |
| Madison, RM | 1 |
| Wenk, ML | 1 |
| Klein, DS | 1 |
6 reviews available for acetaminophen and Bladder Cancer
| Article | Year |
|---|---|
Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Risk; Urinary Bladder Neopl | 2013 |
Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: the role of N,O-sulfonation in chemical carcinogenesis of aromatic amines.
Topics: Acetaminophen; Amines; Animals; Binding Sites; Biological Availability; Carcinogens; Diet; Glucurona | 1983 |
Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Bacteria; Biotransformation; Carcinogens; Cell Lin | 1996 |
Paracetamol.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Carcinogens; Chemical and Drug Induced Liver Injur | 1999 |
[Phenacetin, paracetamol and bladder cancer].
Topics: Acetaminophen; Humans; Phenacetin; Urinary Bladder Neoplasms | 1990 |
Chemically induced renal papillary necrosis and upper urothelial carcinoma. Part 1.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; Carbohy | 1985 |
16 other studies available for acetaminophen and Bladder Cancer
| Article | Year |
|---|---|
Can intravesical application of paracetamol benefit the chemotherapy treatment of bladder cancer?
Topics: Acetaminophen; Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic | 2019 |
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Topics: Acetaminophen; Adjuvants, Immunologic; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Infective A | 2011 |
Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Follow | 2007 |
Modification of carcinogenesis by antioxidants and other compounds.
Topics: Acetaminophen; Animals; Antioxidants; Body Weight; Butylated Hydroxyanisole; Carcinogens; Diethylnit | 1984 |
The role of metabolic activation of analgesics and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; B | 1984 |
Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.
Topics: Acetaminophen; Aminophenols; Animals; Biotransformation; DNA; Glutathione; Humans; Phenacetin; Prost | 1982 |
Acetaminophen and renal and bladder cancer.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Case-Control Studies; Drug Prescriptions; Fema | 1996 |
Priapism of the clitoris.
Topics: Acetaminophen; Aged; Analgesics; Clitoris; Codeine; Diazepam; Fatal Outcome; Female; Humans; Male; M | 1996 |
Acetaminophen and the risk of renal and bladder cancer in the general practice research database.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Case-Control Studies; Databases, Factual; Family Prac | 2001 |
Variations of cortisol hydroxylation and paracetamol metabolism in patients with bladder carcinoma.
Topics: Acetaminophen; Aged; Biotransformation; Carcinoma, Transitional Cell; Humans; Hydrocortisone; Hydrox | 1988 |
Does paracetamol cause urothelial cancer or renal papillary necrosis?
Topics: Acetaminophen; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Kidney Papillary Necr | 1988 |
Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Acetaminophen; Allopurinol; Aminocaproates; Animals; Biphenyl Compounds; Butylhydroxybutylnitrosamin | 1986 |
Heavy phenacetin use and bladder cancer in women aged 20 to 49 years.
Topics: Acetaminophen; Adult; Drug Combinations; Female; Humans; Middle Aged; New York; Phenacetin; Smoking; | 1985 |
Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure.
Topics: Acetaminophen; Animals; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Female; Liver; Live | 1985 |
Phenacetin.
Topics: Acetaminophen; Antipyrine; Denmark; Humans; Kidney Diseases; Kidney Neoplasms; Kidney Papillary Necr | 1969 |
Effect of acetanilide and p-hydroxyacetanilide on the carcinogenicity of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters, and female rats.
Topics: Acetamides; Acetaminophen; Acetanilides; Animals; Carcinogens; Cricetinae; Diet; Female; Fluorenes; | 1973 |